Cargando…
An Fc Domain Protein–Small Molecule Conjugate as an Enhanced Immunomodulator
[Image: see text] Proteins as well as small molecules have demonstrated success as therapeutic agents, but their pharmacologic properties sometimes fall short against particular drug targets. Although the adenosine 2a receptor (A(2A)R) has been identified as a promising target for immunotherapy, sma...
Autores principales: | Chiang, Meng-Jung, Holbert, Marc A., Kalin, Jay H., Ahn, Young-Hoon, Giddens, John, Amin, Mohammed N., Taylor, Martin S., Collins, Samuel L., Chan-Li, Yee, Waickman, Adam, Hsiao, Po-Yuan, Bolduc, David, Leahy, Daniel J., Horton, Maureen R., Wang, Lai-Xi, Powell, Jonathan D., Cole, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954559/ https://www.ncbi.nlm.nih.gov/pubmed/24533830 http://dx.doi.org/10.1021/ja5006674 |
Ejemplares similares
-
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations
por: Peter, Hans-Hartmut, et al.
Publicado: (2020) -
Regulation of CD4(+) and CD8(+) Effector Responses by Sprouty-1
por: Collins, Sam, et al.
Publicado: (2012) -
Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?
por: Schifferli, Alexandra, et al.
Publicado: (2019) -
Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
por: Bohländer, Fabian, et al.
Publicado: (2021) -
Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
por: Nagelkerke, Sietse Q., et al.
Publicado: (2015)